India, March 5 -- Shares of Nurix Therapeutics Inc. (NRIX) are gaining over 8% on Friday morning. The biopharmaceutical company announced pricing of upsized public offering, raising $139.5 million.
NRIX is currently trading at $35.35, up $2.86 or 8.80%, on the Nasdaq.
Nurix Therapeutics priced its offering of 4.5 million common shares at $31.00 per share. The offering was upsized from the previously announced size of 4 million shares.
The proceeds are expected to be $139.5 million. The offering is expected to close on March 9, 2021.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....